ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, ...
In its effort to correlate genomic structure with gene function, the 4D Nucleome Consortium (4DN), led by Job Dekker, Ph.D., ...
BIOMAKERS, a precision medicine and oncology intelligence company headquartered in San Francisco, today announced the closing of an additional $8 million. The financing marks a key inflection point as ...
BIOMAKERS, a precision medicine and oncology intelligence company headquartered in San Francisco, today announced the closing of an additional $8 million. The financing marks a key inflection point as ...
Preserved by dry, cool air and darkness, the cheetah mummies are offering scientists DNA insights into a lost population and ...
The National Defense Authorization Act for Fiscal Year 2026, signed into law on 18 December 2025, includes the BIOSECURE Act (the Act), ...
Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, notes William Audeh, MD, MS.
Research co-led by King's College London and Sidra Medicine, Qatar, has produced the most detailed map to date of large-scale ...
Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...
This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback